Drug Delivery and Therapy Strategies for Osteoporosis Intervention
With the advent of the aging society, osteoporosis (OP) risk increases yearly. Currently, the clinical usage of anti-OP drugs is challenged by recurrent side effects and poor patient compliance, regardless of oral, intravenous, or subcutaneous administration. Properly using a drug delivery system or...
Main Authors: | Mingyang Ma, Huiling Zeng, Pei Yang, Jiabing Xu, Xingwang Zhang, Wei He |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/18/6652 |
Similar Items
-
Microneedles in Action: Microneedling and Microneedles-Assisted Transdermal Delivery
by: Dong-Jin Lim, et al.
Published: (2022-04-01) -
Transdermal Delivery of Drugs with Microneedles—Potential and Challenges
by: Kevin Ita
Published: (2015-06-01) -
Wearable patches for transdermal drug delivery
by: Jiahui He, et al.
Published: (2023-06-01) -
Microneedles for in situ tissue regeneration
by: Linyu Long, et al.
Published: (2023-04-01) -
Polylactic Acid and Polycaprolactone Blended Cosmetic Microneedle for Transdermal Hispidin Delivery System
by: Seungyeon Lee, et al.
Published: (2021-03-01)